1071925-72-8

Basic information

• Product Name: N-(3-(thiophen-3-yl)phenyl)-4-(pyridin-3-yl)benzamide
• CAS NO: 1071925-72-8
• Molecular Weight: 356.448
• Mol File: 1071925-72-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-(thiophen-3-yl)phenyl)-4-(pyridin-3-yl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-(thiophen-3-yl)phenyl)-4-(pyridin-3-yl)benzamide(1071925-72-8)
• EPA Substance Registry System: N-(3-(thiophen-3-yl)phenyl)-4-(pyridin-3-yl)benzamide(1071925-72-8)

Safety Data

• Hazardous Substances Data: 1071925-72-8(Hazardous Substances Data)

Upstream product

• 161886-96-0 3‐(thiophen‐3‐yl)aniline 

Relevant articles and documents

Structural modifications of salicylates: Inhibitors of human CD81-receptor HCV-E2 interaction

Starting point of the present paper was the result of a virtual screening using the open conformation of the large extracellular loop (LEL) of the CD81-receptor (crystal structure: PDB-ID: 1G8Q). After benzyl salicylate had been experimentally validated to be a moderate inhibitor of the CD81-LEL-HCV-E2 interaction, further optimization was performed and heterocyclic-substituted benzyl salicylate derivatives were synthesized. The compounds were tested for their ability to inhibit the interaction of a fluorescence-labeled antibody to CD81-LEL using HUH7.5 cells. No compound showed an increase concerning the inhibition of the protein-protein interaction compared to benzyl salicylate.